Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: Relation to corticosteroid therapy and vitamin D receptor gene polymorphisms

References

• Buchanan GR. Overview of ITP treatment modalities in children. Blut 1989; 59(1)96–104
   PubMedGoogle Scholar
• Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168–186
   PubMed Web of Science ®Google Scholar
• Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: Retrospective and prospective survey in Germany. Semin Thromb Hemost 2001; 27(3)253–267
   PubMedGoogle Scholar
• Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117(16):4190–4207
   Google Scholar
• Blanchette V, Carcao M. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol 2000; 37(3)299–314
   PubMedGoogle Scholar
• Dilber C, Dagdemir A, Albayrak D, Albayrak S, Kalayci AG, Aliyazicioglu Y, Basoglu T. Reduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisolone. Bone 2004; 35(1)306–311
   PubMedGoogle Scholar
• Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: Pathophysiology and therapy. Osteoporos Int 2007; 18: 1319–1328
   PubMed Web of Science ®Google Scholar
• Manelli F, Giustina A. Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab 2000; 11(3)79–85
   PubMedGoogle Scholar
• Bid HK, Mishra DK, Mittal RD. Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Prev 2005; 6(2)147–152
   PubMedGoogle Scholar
• Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371(1–2)1–12
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009; 113(11)2386–2393
   PubMed Web of Science ®Google Scholar
• Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilek S, Lorenc RS, Tosi LL, Ward KA, Ward LM, et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: The 2007 ISCD Pediatric Official Positions. J Clin Densitom 2008; 11(1)43–58
   PubMed Web of Science ®Google Scholar
• Gafni RI, Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy X-ray absorptiometry (DEXA). J Pediatr 2004; 144(2)253–257
   PubMed Web of Science ®Google Scholar
• Bowden SA, Robinson RF, Carr R, Mahan JD. Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics 2008; 121(6)e1585–e1590
   Google Scholar
• Quesada JM, Casado A, Diaz C, Barrios L, Cuenca-Aceve do R, Dorado G. Allele-frequency determination of Bsm1 and Fok1 polymorphisms of the VDR gene by quantitative real-time PCR (QRT-PCR) in pooled genomic DNA samples. J Steroid Biochem Mol Biol 2004; 89–90: 209–214
   PubMedGoogle Scholar
• Lu PW, Cowell CT, LLoyd-Jones SA, Briody JN, Howman-Giles R. Volumetric bone mineral density in normal subjects, aged 5–27 years. J Clin Endocrinol Metab 1996; 81: 1586–1590
   PubMed Web of Science ®Google Scholar
• Civitelli R, Armamento-Villareal R, Napoli N. Bone turnover markers: Understanding their value in clinical trials and clinical practice. Osteoporos Int 2009; 20(6)843–851
   PubMed Web of Science ®Google Scholar
• Olney RC. Mechanisms of impaired growth: Effect of steroids on bone and cartilage. Horm Res 2009; 72(Suppl 1)30–35
   PubMedGoogle Scholar
• Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses. Rheumatology (Oxford) 2000; 39: 1383–1389
   PubMed Web of Science ®Google Scholar
• Ferrara M, Borrelli B, Greco N, Coppola L, Coppola A, Simeone G, Perrotta A, Capozzi L, Esposito L. Side effects of corticosteroid therapy in children with chronic idiopathic thrombocytopenic purpura. Hematology 2005; 10(5)401–403
   PubMed Web of Science ®Google Scholar
• Yildirim ZK, Büyükavci M, Eren S, Orbak Z, Sahin A, Karakelleoğlu C. Late side effects of high-dose steroid therapy on skeletal system in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2008; 30(10)749–753
   PubMedGoogle Scholar
• Shouman MG, Abdallah N, Abd El Meguid Ak, Salama EE, El Ghoroury E, Abou Ismai LA, Emara NM. Bone mineral density markers in children with steroids sensitive idiopathic nephrotic syndrome. Int J Acad Res 2010; 2(3)150–156
   Google Scholar
• Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res 2009; 24(3)503–513
   PubMedGoogle Scholar
• Shimada A, Kanazawa Y, Motohashi Y, Yamada S, Maruyama T, Ikegami H, Awata T, Kawasaki E, Kobayashi T, Nakanishi K, et al. Japanese Study Group on Type 1 Diabetes Genetics. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 2008;30(4):207–211
   Google Scholar
• Luo XY, Yang MH, Wu FX, Wu LJ, Chen L, Tang Z, Liu NT, Zeng XF, Guan JL, Yuan GH. Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 2012; 21(1)53–9
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang C, Liang J, Zhou X, Zheng F, Fan Y, Shi Q. The vitamin D receptor Fok1 polymorphism and bone mineral density in Chinese children. Clin Chim Acta 2008; 395(1–2)111–114
   PubMedGoogle Scholar
• Tantawy AA, El Kholy M, Moustafa T, Elsedfy HH. Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol Rev 2008; 6(1)132–135
   PubMedGoogle Scholar
• Diogenes ME, Bezerra FF, Cabello GM, Cabello PH, Mendonça LM, Oliveira Júnior AV, Donangelo CM. Vitamin D receptor gene FokI polymorphisms influence bone mass in adolescent football (soccer) players. Eur J Appl Physiol 2010; 108(1)31–38
   PubMedGoogle Scholar
• Strandberg S, Nordström P, Lorentzon R, Lorentzon M. Vitamin D receptor start codon polymorphism (FokI) is related to bone mineral density in healthy adolescent boys. J Bone Miner Metab 2003; 21(2)109–113
   PubMedGoogle Scholar
• Ozaydin E, Dayangac-Erden D, Erdem-Yurter H, Derman O, Coşkun T. The relationship between vitamin D receptor gene polymorphisms and bone density, osteocalcin level and growth in adolescents. J Pediatr Endocrinol Metab 2010; 23(5)491–496
   PubMedGoogle Scholar
• Lorentzon M, Lorentzon R, Nordström P. Vitamin D receptor gene polymorphism is related to bone density, circulating osteocalcin, and parathyroid hormone in healthy adolescent girls. J Bone Miner Metab 2001; 19(5)302–307
   PubMedGoogle Scholar